Yoshua Esquenazi
Affiliations: | Neurosurgery | University of Texas Houston Medical School, Houston, TX, United States |
Google:
"Yoshua Esquenazi"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaboratorChirag B Patel | collaborator | University of Texas Houston Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang DH, Fujita Y, Dono A, et al. (2024) The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathologica Communications. 12: 13 |
Kata K, Rodriguez-Quintero JC, Arevalo OD, et al. (2022) BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 1193-1202.e6 |
Dono A, Mitra S, Shah M, et al. (2021) PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. Journal of Neuro-Oncology |
Shah M, Takayasu T, Zorofchian Moghadamtousi S, et al. (2021) Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies. The Journal of Molecular Diagnostics : Jmd. 23: 171-180 |
Patrizz A, Dono A, Zhu P, et al. (2021) Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes? Journal of Neuro-Oncology |
Kata K, Quintero JCR, Arevalo-Espejo O, et al. (2021) INNV-06. BRAF AND MEK DUAL INHIBITORS THERAPY IN RECURRENT OR ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA (PXA) Neuro-Oncology. 23: vi106-vi106 |
Xia H, Avci NG, Akay Y, et al. (2020) Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation. Ieee Open Journal of Engineering in Medicine and Biology. 1: 9-16 |
Xia H, Avci NG, Akay Y, et al. (2020) Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation. Ieee Open Journal of Engineering in Medicine and Biology. 1: 9-16 |
Lopez-Rivera V, Dono A, Abdelkhaleq R, et al. (2020) Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location. Clinical Neurology and Neurosurgery. 199: 106282 |
Takayasu T, Shah M, Dono A, et al. (2020) Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors. Scientific Reports. 10: 14326 |